You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 619 Evaluating the effectiveness of targeted ADC therapy in a patient-derived ex vivo tumoroid model, 3D-EX, for quantitative tumor cell killing

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
619 Evaluating the effectiveness of targeted ADC therapy in a patient-derived ex vivo tumoroid model, 3D-EX, for quantitative tumor cell killing

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202065012
Dec 20201803
Jan 20211204
Feb 20212004
Mar 20213405
Apr 20211404
May 2021402
Jun 2021007
Jul 2021005
Aug 2021006
Sep 2021004
Oct 202118017
Nov 20218017
Dec 2021603
Jan 20222004
Feb 20221205
Mar 2022402
Apr 20222401
May 20222201
Jun 2022802
Jul 20221202
Aug 20221901
Sep 20221801
Oct 20221000
Nov 2022800
Dec 20221603
Jan 20231800
Feb 20231200
Mar 2023800
Apr 20231002
May 20231401
Jun 2023402
Jul 2023804
Aug 2023801
Sep 2023601
Oct 2023402
Nov 20232004
Dec 20232402
Jan 20242200
Feb 20241200
Mar 2024600
Apr 2024801
May 20241600
Jun 20243400
Jul 20241600
Aug 20241400
Sep 20242201
Oct 20242708
Nov 20241003
Dec 20241005
Jan 2025805
Feb 20251603
Mar 2025009
Apr 2025103
May 2025004
Jun 2025003
Total7300179